This year has brought political uncertainties for science, with concerns about how leaving the EU might affect access to international talent, funding opportunities, and regulation, to name but a few. World leading scientific innovation is a major driver of the UK economy and the Golden Triangle is at the heart of that. To keep building on this, new lab space and innovation hubs have been developed this year, showing the world that we are still open for science.
The Francis Crick Institute
The Crick was opened on 9 November by The Queen and The Duke of Edinburgh. It will be home to 1,250 scientists and a further 250 support staff at full capacity in 2017. In building the new laboratories, the Crick partners aim to create a world-leading centre of biomedical research and innovation in the heart of London.
Dedicated to research excellence, it has the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease. Its work is helping to develop new treatments for illnesses such as cancer, heart disease, stroke, neurodegenerative conditions and infectious diseases. It promotes connections between researchers, between disciplines and between academic institutions, healthcare organisations and businesses.
The Institute’s fresh approach extends to progressing research breakthroughs to practical applications in hospitals and pharmacies. As well as being a substantial centre in its own right, the Francis Crick Institute exerts wider influence as a flagship for UK biomedical science.
Find out more here: https://www.crick.ac.uk/our-building/
At Londoneast-uk, a post-incubator science facility for small and growing companies was launched on 6 October by the Mayor of London, Sadiq Khan. The Cube has been created with support by a £500,000 investment loan from the London Enterprise Panel’s Growing Places Fund (GPF) which has helped finance the post-incubator science facility. The GPF loan unlocked £2.5 million of private investment from SOG Group, the owner and operator of londoneast-uk, along with match funding from the London Borough of Barking and Dagenham, worth a further £826,000.
The Cube will ultimately accommodate up to 15 science-related businesses employing more than 90 people. It was created by refurbishing facilities on a site formerly owned by pharmaceutical manufacturer Sanofi and transforming them for use by multiple firms.
Imperial’s White City Campus
White City Campus will provide state-of-the-art space for translating research ideas into direct applications and spin-out companies. The Translation & Innovation Hub, or “I-HUB” for short, opened this year, with fully serviced laboratories, write-up and office spaces providing scalable, high specification accommodation to translate and commercialise research and ideas. Providing 187,000 square foot of new laboratory, incubator, accelerator and office space, the facility will enable the co-location of start-ups, entrepreneurs, and major corporations alongside Imperial’s academic community.
The Molecular Sciences Research Hub is due for completion in 2017 and the 13-storey Michael Uren Biomedical Engineering Research Hub is due to complete in 2019.
Find out more here: http://www.imperial.ac.uk/white-city-campus/
Cambridge Biomedical Campus
The expansion of the Campus is taking place in two phases. Phase 1 comprises 70 acres of which one third will accommodate Cambridge University Hospitals with the remaining two thirds for commercial and other uses. Over 3,500 new jobs will be created and 75,000 sqm of research and development and clinical space will be delivered.
The Campus is already a world-renowned centre of clinical and healthcare excellence and has been a growing life sciences hub since the early 1960s. The approved plans for the next phase of the campus will bring forward development of an additional 23 acres of land, carefully masterplanned with a ‘landscape first’ approach. Extensive consultation and engagement helped shape proposals for the expansion which will incorporate state-of-the-art research and development facilities alongside new clinical space for Cambridge University Hospitals, further enhancing this thriving and collaborative community.
Find out more here: http://cambridge-biomedical.com/about-the-campus-2/masterplan-2/